ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2018-10, Vol.29, p.viii417-viii418
Hauptverfasser:	Boudot, A., Huang, X., Murphy, S., Appleman, V., Xu, H., Cheung, N.-K., Macbeath, G.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	viii418
container_issue
container_start_page	viii417
container_title	Annals of oncology
container_volume	29
creator	Boudot, A. Huang, X. Murphy, S. Appleman, V. Xu, H. Cheung, N.-K. Macbeath, G.
description
doi_str_mv	10.1093/annonc/mdy288.043
format	Article
fullrecord	<record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy288_043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419496270</els_id><sourcerecordid>32137045</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2303-21ddebd4b08a9aeb141d0fda45a850666f18284ce49f3e0b52b35d595df1be873</originalsourceid><addsrcrecordid>eNp9kEtLw0AUhQdRbK3-ADcye0l755UmuqqlWqHgg7oO87gpI2lSZtJC_72RqEtXZ3O-w-Ej5JrBmEEuJrqum9pOtu7Is2wMUpyQIVNpnmQg2SkZQs5FMlVCDshFjJ8AkOY8PycDwZmYglRD8jZ7eE0YwB2d0RbboA-6wrqlxscdWl96S9eJxaqiWG_0xtcbquvWm8YdadkEuly881sam8o72u63TYiX5KzUVcSrnxyRj8fFer5MVi9Pz_PZKrFcgEg4cw6NkwYynWs0TDIHpdNS6UxBmqYly3gmLcq8FAhGcSOUU7lyJTOYTcWIsH7XhibGgGWxC36rw7FgUHzrKXo9Ra-n6PR0zE3P7PZmi-6P-PXRFe77AnbPDx5DEa3H2qLzAW1buMb_M_8FxnN27A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Boudot, A. ; Huang, X. ; Murphy, S. ; Appleman, V. ; Xu, H. ; Cheung, N.-K. ; Macbeath, G.</creator><creatorcontrib>Boudot, A. ; Huang, X. ; Murphy, S. ; Appleman, V. ; Xu, H. ; Cheung, N.-K. ; Macbeath, G.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy288.043</identifier><identifier>PMID: 32137045</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii417-viii418</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32137045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boudot, A.</creatorcontrib><creatorcontrib>Huang, X.</creatorcontrib><creatorcontrib>Murphy, S.</creatorcontrib><creatorcontrib>Appleman, V.</creatorcontrib><creatorcontrib>Xu, H.</creatorcontrib><creatorcontrib>Cheung, N.-K.</creatorcontrib><creatorcontrib>Macbeath, G.</creatorcontrib><title>ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLw0AUhQdRbK3-ADcye0l755UmuqqlWqHgg7oO87gpI2lSZtJC_72RqEtXZ3O-w-Ej5JrBmEEuJrqum9pOtu7Is2wMUpyQIVNpnmQg2SkZQs5FMlVCDshFjJ8AkOY8PycDwZmYglRD8jZ7eE0YwB2d0RbboA-6wrqlxscdWl96S9eJxaqiWG_0xtcbquvWm8YdadkEuly881sam8o72u63TYiX5KzUVcSrnxyRj8fFer5MVi9Pz_PZKrFcgEg4cw6NkwYynWs0TDIHpdNS6UxBmqYly3gmLcq8FAhGcSOUU7lyJTOYTcWIsH7XhibGgGWxC36rw7FgUHzrKXo9Ra-n6PR0zE3P7PZmi-6P-PXRFe77AnbPDx5DEa3H2qLzAW1buMb_M_8FxnN27A</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Boudot, A.</creator><creator>Huang, X.</creator><creator>Murphy, S.</creator><creator>Appleman, V.</creator><creator>Xu, H.</creator><creator>Cheung, N.-K.</creator><creator>Macbeath, G.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors</title><author>Boudot, A. ; Huang, X. ; Murphy, S. ; Appleman, V. ; Xu, H. ; Cheung, N.-K. ; Macbeath, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2303-21ddebd4b08a9aeb141d0fda45a850666f18284ce49f3e0b52b35d595df1be873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boudot, A.</creatorcontrib><creatorcontrib>Huang, X.</creatorcontrib><creatorcontrib>Murphy, S.</creatorcontrib><creatorcontrib>Appleman, V.</creatorcontrib><creatorcontrib>Xu, H.</creatorcontrib><creatorcontrib>Cheung, N.-K.</creatorcontrib><creatorcontrib>Macbeath, G.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boudot, A.</au><au>Huang, X.</au><au>Murphy, S.</au><au>Appleman, V.</au><au>Xu, H.</au><au>Cheung, N.-K.</au><au>Macbeath, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii417</spage><epage>viii418</epage><pages>viii417-viii418</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32137045</pmid><doi>10.1093/annonc/mdy288.043</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0923-7534
ispartof	Annals of oncology, 2018-10, Vol.29, p.viii417-viii418
issn	0923-7534 1569-8041
language	eng
recordid	cdi_crossref_primary_10_1093_annonc_mdy288_043
source	EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title	ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A17%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ABP-100:%20A%20tetravalent%20bispecific%20T-cell%20engaging%20antibody%20for%20HER2+%20solid%20tumors&rft.jtitle=Annals%20of%20oncology&rft.au=Boudot,%20A.&rft.date=2018-10&rft.volume=29&rft.spage=viii417&rft.epage=viii418&rft.pages=viii417-viii418&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy288.043&rft_dat=%3Cpubmed_cross%3E32137045%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32137045&rft_els_id=S0923753419496270&rfr_iscdi=true